EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma AG & Co. KGaA
- EQS-News: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
The issuer is solely responsible for the content of this announcement. - SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
First U.S. manufacturing facility to fill demand for domestic supply of glass and polymer prefillable syringes that deliver mRNA, GLP-1, and other therapies
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. - SCHOTT Pharma a pioneer in pharmaceutical drug containment solutions and delivery systems, will build the first U.S. facility to manufacture prefillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.
- On average, more than 25,000 injections per minute are provided to patients worldwide through a product produced by SCHOTT Pharma.